LIVE WEBINAR
Applications of iPSC Gene Editing Technologies in Biomedical Research
Discover how advanced gene editing technologies are being applied to human iPSCs for drug discovery, disease modeling, and regenerative medicine. This webinar shares technical strategies for improving iPSC workflows and provides insights into overcoming common challenges in pluripotency maintenance and monoclonal selection.
DATE
09:00 AM – 10:00 AM PDT
LOCATION
Online Webinar | YouTube
Webinar Overview
This webinar explores how gene editing technologies are expanding the potential of
human iPSCs for disease modeling, drug discovery, and regenerative therapies. While iPSCs offer significant
promise for in vitro and translational research, challenges such as low induction efficiency, complex
culture conditions, and clinical translation hurdles must be addressed to fully realize their value.
Led by stem cell and gene editing expert Lily Fan, the session discusses practical strategies for improving
iPSC gene editing workflows, maintaining pluripotency during differentiation, and overcoming monoclonal
selection difficulties. Attendees will gain insights into the latest applications of gene-edited iPSCs
across functional genomics, regenerative medicine, and preclinical screening.
Topic Covered
- Applications of gene-edited iPSCs in drug development, regenerative medicine, and functional genomics
- Challenges in iPSC induction, expansion, and differentiation
- Strategies to maintain pluripotency and streamline monoclonal selection
- Translational insights to enhance the clinical utility of gene-edited iPSCs
Who Should Attend
- Researchers working with iPSCs and stem cell engineering
- Geneticists, molecular biologists, and translational medicine scientists
- Professionals in drug discovery and regenerative therapy development
- Graduate students and early-career researchers in biotechnology or life sciences
Attend this Webinar to:
- Explore practical uses of iPSC gene editing in biomedical research
- Understand and overcome common technical challenges
- Gain strategies for improving iPSC workflows and translational outcomes
- Learn from an expert with deep industry and academic experience
Webinar Presenter
{{value.name}}
{{value.title}}
{{value.company}}
{{value.descript}}
Discover Our Solutions
Cyagen supports iPSC-based research with a full suite of customizable services, including gene-edited cell
line generation and disease-relevant iPSC models. From reprogramming and precise editing to guided
differentiation, our solutions are designed to help researchers streamline experimental workflows and build
clinically relevant platforms for drug screening, disease modeling, and cell therapy development.
{{ value.label }}
{{ value.name }}
Explore
Request Information About This Webinar
Whether you're joining live or catching up later, fill out the form to receive materials or updates related to this webinar.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.